Ledger.Open graph →
SEC Form D · filed December 13, 2017

Metacrine, Inc

Offering
$22.0M
Sold
$22.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Patricia Millican · San Diego, CAExecPatricia Millican · San Diego, CAExecRonald Evans · San Diego, CADirectorLilly J. Farahnakian · Chicago, ILDirectorAmir Nashat · Cambridge, MADirectorEric Stewart · Robinson, ILExec · DirectorKristina Burow · San Diego, CADirectorRobert Adelman · San Diego, CADirectorLawrence C. Mandes · DENVER, CODirectorWilliams M. Clark · Austin, TXDirectorAlaina Danley · Grand Cayman, Cayman IslandsDirectorMichael Hylander · San Diego, CAExec · DirectorCarol Gallagher · San Diego, CADirectorJames Deters · DENVER, CODirectorRichard Heyman · San Diego, CADirectorMurray Markiles · Sherman Oaks, CADirectorKen Song · San Diego, CAExec · DirectorCarol Gallagher · San Diego, CADirectorMatthew Ginsberg · Eugene, ORDirectorDennis Capovilla · Eugene, ORDirectorAmir Nashat · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗